Synapse

← Cancer Nanotechnology

Papers in Cancer Nanotechnology

Page 1 · newest first

  1. The role of platelet-derived microparticles in the progression of acute myeloid leukemia and their application in cancer nanotechnologyCancer Nanotechnology · 2026
  2. Lipid nanoparticle platforms for p53-targeted cancer therapyCancer Nanotechnology · 2026
  3. Targeted delivery of boron depots containing immune adjuvant to achieve efficient cancer therapy via a combination of BNCT and cancer vaccineCancer Nanotechnology · 2026
  4. Magnetically-guided hyaluronic acid-decorated PLGA nanoparticles for enhanced tumor selective doxorubicin delivery in triple-negative breast cancerCancer Nanotechnology · 2026
  5. Efficient delivery of DMDD by an iron-engineered mesoporous organosilica nanoplatform reshapes the breast cancer immune microenvironment via autophagy activation and immune checkpoint modulationCancer Nanotechnology · 2026
  6. Stem cell-derived extracellular vesicles in cancer theranostics: dual regulatory mechanisms, engineering strategies, and clinical translationCancer Nanotechnology · 2026
  7. Enhanced cytotoxicity in cisplatin-tolerant oral squamous cell carcinoma 3D models through nanoparticle-mediated Pt(IV) drug deliveryCancer Nanotechnology · 2026
  8. Self-assembled products from natural active compounds: mechanisms and applications in cancer therapyCancer Nanotechnology · 2026
  9. PLLA–ZnO nanowire nano-vaccine orchestrates balanced Th1/Th2 immunity and confers prophylactic antitumor protectionCancer Nanotechnology · 2026
  10. Bioinspired cell-hitchhiking nanotherapeutics in acute myeloid leukemia: targeting the EV–platelet–NET axis and the leukemic bone marrow nicheCancer Nanotechnology · 2026
  11. Edible source-derived exosome-like nanoparticles for hepatocellular carcinoma: mechanisms, engineering strategies, and translational challengesCancer Nanotechnology · 2026
  12. Hyaluronic acid-modified taurine-polydopamine nanoparticles for combined photothermal-immunotherapy of gastric cancer through microenvironment regulationCancer Nanotechnology · 2026
  13. Platelet–neutrophil cooperation in premetastatic niche formation: from NETosis and stromal conditioning to nanotherapeutic interceptionCancer Nanotechnology · 2026
  14. Selaginella doederleinii–derived extracellular vesicle-like particles induce ferroptosis via the xCT/GPX4 axis and are associated with metabolic and gut microbiota alterations in hepatocellular carcinomaCancer Nanotechnology · 2026
  15. Lipid-based nanomedicine for hepatocellular carcinoma: flavonoid-enhanced, pathway-specific siRNA delivery strategies and clinical progressCancer Nanotechnology · 2026
  16. Nano-enabled delivery of natural products and combinatorial chemotherapy for triple-negative breast cancers: mechanisms, synergy, and translational challengesCancer Nanotechnology · 2026
  17. Ultrasound-assisted glycyrrhetinic acid/nitric oxide co-loaded albumin nanoparticles for the synergistic treatment of hepatocellular carcinomaCancer Nanotechnology · 2026
  18. Multimodal nanomedicine for precision colorectal cancer management: integrated diagnosis, targeted therapy, and personalized theranosticsCancer Nanotechnology · 2026
  19. Gold nanostructure-based cancer photothermal therapy: a comprehensive systematic review, meta-analysis, and dose–response evaluationCancer Nanotechnology · 2026
  20. Improved anticancer efficacy of cisplatin co-delivered with nisin-decorated solid lipid nanoparticlesCancer Nanotechnology · 2026
  21. Piezoelectric nanozymes: a new frontier for next-generation tumor therapeuticsCancer Nanotechnology · 2026
  22. Multi-omics convergence screening reveals dual-cargo antitumor mechanisms of orally administered Houttuynia cordata-derived exosome-like nanoparticlesCancer Nanotechnology · 2026
  23. Efficacy of nanomaterials in the treatment of head and neck cancer: a systematic reviewCancer Nanotechnology · 2026
  24. Biogenic platinum nanozymes: a core-corona structure-activity framework for cancer theranostics, antimicrobial, anti-inflammatory, and anticoagulant applicationsCancer Nanotechnology · 2026
  25. Global research trends and collaborations on small interfering RNA in cancer: insights and prospects (2002–2024)Cancer Nanotechnology · 2026
  26. Tumor-targeted nanobubbles delivering PFP/siFGFR1 for US imaging and overcoming enzalutamide-resistant in prostate cancerCancer Nanotechnology · 2026
  27. Direct-current electric fields tune functionalized gold nanoparticle uptake and mitochondrial remodelling in glioblastoma cellsCancer Nanotechnology · 2026
  28. Metal–organic framework-based therapeutic strategies for hepatocellular carcinoma: current advances and future perspectivesCancer Nanotechnology · 2026
  29. Chemo-phototherapeutic co-delivery nanosystems for colorectal cancer: a reviewCancer Nanotechnology · 2026
  30. Liposomal nanocarriers in retinoblastoma: from molecular design to clinical translationCancer Nanotechnology · 2026
  31. Translational progress of stimulus-responsive smart nanocarrier platforms for cancer theranostics: a reviewCancer Nanotechnology · 2026
  32. Fibronectin-modified pH/ATP-responsive ZIF-90 nanoparticles induce ferroptosis in colorectal cancer via mitochondrial dysfunctionCancer Nanotechnology · 2026
  33. Combinational CSF1R/PD-L1 targeting by BM-MSC-derived exosome–liposome hybrid orchestrates tumor-associated macrophage phagocytosis in an in vitro tumor-microenvironment-dependent mannerCancer Nanotechnology · 2026
  34. Luteolin-based nanocomposites in cancer: rewiring oncogenic signaling and non-coding RNA networks to restore programmed cell deathCancer Nanotechnology · 2026
  35. Therapeutic and preventive potential of novel sulfur nanoparticles via immunomodulation in hepatocellular carcinomaCancer Nanotechnology · 2026
  36. Recent advances in phytomedicine-based nano-antioxidants for redox-modulated cancer therapyCancer Nanotechnology · 2026
  37. o-carborane encapsulated into polymeric micelles for proton boron capture therapyCancer Nanotechnology · 2026
  38. Sodium new houttuyfonate and doxorubicin co-loaded liposomes for the treatment of cervical cancerCancer Nanotechnology · 2026
  39. Performance of chelating agent modulated Β-cyclodextrin coated zinc ferrite nanocarriers for 5-FU delivery and cytotoxicity in glioblastomaCancer Nanotechnology · 2026
  40. Artificial intelligence-driven methods and nanoparticle-based biosensors for rapid and sensitive detection of EGFR mutations in non-small cell lung cancerCancer Nanotechnology · 2026
  41. Chemodynamic therapy-cooperatively enhanced gambogic acid-iron-doxorubicin nanozymes for chemotherapy sensitization in liver cancerCancer Nanotechnology · 2026
  42. In vivo evaluation of the anticancer efficacy of melatonin–selenium nanoparticles in a mouse modelCancer Nanotechnology · 2026
  43. Nanometal-mediated cuproptosis and ferroptosis: emerging paradigms in hepatocellular carcinoma therapyCancer Nanotechnology · 2026
  44. Engineered exosomes as natural nanocarriers for precision drug and gene delivery in cancer therapyCancer Nanotechnology · 2026
  45. Sustainable nanomedicine: exploiting fruit and vegetable waste-derived extracts for targeted anticancer applicationCancer Nanotechnology · 2026
  46. Targeted DYRK1A/mTOR co-delivery system for head and neck squamous cell carcinoma therapyCancer Nanotechnology · 2026
  47. Metal polyphenol nanocomplexes for targeting treatment of breast tumor and lung cancerCancer Nanotechnology · 2026
  48. Nanotechnology in oral cancer: a theranostic approach for diagnosis, targeted therapy, and clinical translationCancer Nanotechnology · 2026
  49. Preparation of oridonin-loaded microalgae-derived small extracellular vesicles and their anti-colorectal cancer efficacy evaluationCancer Nanotechnology · 2026
  50. Precision oncology with nanozymes: multifunctional platforms for targeted tumor treatmentCancer Nanotechnology · 2026